Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies

J Zheng, B Li, Y Wu, X Wu, Y Wang - Journal of Medicinal …, 2023 - ACS Publications
As a predominant type II protein arginine methyltransferase, PRMT5 plays critical roles in
various normal cellular processes by catalyzing the mono-and symmetrical dimethylation of …

[HTML][HTML] The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: from experimental study to clinical application

J Ning, L Chen, G Xiao, Y Zeng, W Shi… - Biomedicine & …, 2023 - Elsevier
Tumor metastasis is the leading cause of mortality among advanced cancer patients.
Understanding its mechanisms and treatment strategies is vital for clinical application …

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer

Y Shi, Y Niu, Y Yuan, K Li, C Zhong, Z Qiu, K Li… - Nature …, 2023 - nature.com
Although oxaliplatin-based chemotherapy has been effective in the treatment of
hepatocellular carcinoma (HCC), primary or acquired resistance to oxaliplatin remains a …

[HTML][HTML] STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma

K Jiang, X Yin, Q Zhang, J Yin, Q Tang, M Xu, L Wu… - Redox biology, 2023 - Elsevier
Radioresistance is the major reason for the failure of radiotherapy in esophageal squamous
cell carcinoma (ESCC). Previous evidence indicated that stanniocalcin 2 (STC2) participates …

PRMT5 activates KLF5 by methylation to facilitate lung cancer

H Zhou, J Chang, J Zhang, H Zheng… - Journal of cellular …, 2024 - Wiley Online Library
The highly expressed oncogenic factor Krüppel‐like factor 5 (KLF5) promotes various
cancerous processes, such as cell growth, survival, anti‐apoptosis, migration and …

Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer

S Liu, Z Liu, C Piao, Z Zhang, C Kong, L Yin… - Journal of Experimental & …, 2022 - Springer
Abstract Background Protein arginine methyltransferases (PRMTs) regulate protein
biological activity by modulating arginine methylation in cancer and are increasingly …

Therapeutic advantage of targeting PRMT5 in combination with chemotherapies or EGFR/HER2 inhibitors in triple-negative breast cancers

R Dakroub, S Huard, Y Hajj-Younes… - … Cancer: Targets and …, 2023 - Taylor & Francis
Purpose Triple-negative breast cancer (TNBC) is the most aggressive breast cancer
subgroup characterized by a high risk of resistance to chemotherapies and high relapse …

Alpha‐synuclein promotes PRMT5‐mediated H4R3me2s histone methylation by interacting with the BAF complex

T Nakamura, N Sugeno, T Hasegawa… - The FEBS …, 2024 - Wiley Online Library
α‐Synuclein (αS) is a key molecule in the pathomechanism of Parkinson's disease. Most
studies on αS to date have focused on its function in the neuronal cytosol, but its action in …

[HTML][HTML] Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification

M Chen, Q Zhang, S Zheng, X Guo, L Cao… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Cancer progression depends on the communication between tumor cells and tumor
microenvironment. Cancer-associated fibroblasts (CAFs) are a major component of stromal …

PRMT5 as a potential therapeutic target in MYC-amplified medulloblastoma

D Kumar, S Jain, DW Coulter, SS Joshi, NK Chaturvedi - Cancers, 2023 - mdpi.com
Simple Summary Medulloblastoma is the most prevalent intracerebellar pediatric brain
tumor, accounting for approximately 20% of all childhood brain tumors and over 60% of …